Burning Rock is dedicated to delivering comprehensive cancer genomic solutions for pharmaceutical
companies, facilitating anti-cancer drug development from biomarker discovery to commercialization.
1
Pre-clinical Stage
Pre-clinical Biomarker Research
Target screening based on cell lines and PDX models
MoA Research
2
Pre-clinical Stage
Big Data Biomarker Research
BNR internal database, 700K+ data analysis data reports
TCGA/COSMIC/GTEX analysis
Analysis of biomarkers in patient populations expected to benefit
Our global operation system is designed to support Multi-Regional Clinical Trials (MRCT), ensuring
seamless coordination and efficient management across multiple centers worldwide.
MRCTs
Learn more about how Burning Rock Dx can partner
with you to support your clinical trial development
We would like to collect certain personal information about you through cookies and similar technologies
in order to personalize the site for you, improve the performance of the site, and support our marketing
efforts. By clicking “Accept All”, you confirm that we have your consent to collect and process your
personal information in accordance with our Privacy Policy, which may include
online targeted and social media advertising in some instances. You can by clicking “Reject All”, you
can reject all cookies except for Strictly Necessary Cookies."
Contact Our Biopharma Team to Learn More
By submitting this form, or by checking the box above the “Submit” button (if applicable),
you agree that your information will be processed according to Burning Rock’s privacy policy
to provide you with the information and/or general marketing communications (if applicable)
you have requested here. Burning Rock Dx is committed to protecting and respecting your
privacy.
Pre-clinical Stage 
Pre-clinical Stage 
Early Clinical Stage 
Whole Clinical Stage 
Pivotal Clinical Stage 
Post-marketing 
